On Friday, February 1, KyungDong Pharm held a launch ceremony for Neucapen Capsules, a treatment for neuropathic pain. By inhibiting calcium influx at nerve endings, Neucapen reduces excessive release of excitatory neurotransmitters and relieves pain associated with peripheral neuropathy and postherpetic neuralgia.